• Home
• About CBW
  • State-Of-The-Art Facility
  • Service Area
  • Privacy Policy
  • Featured Vendors
  • F.A.Q.
• Products
  • Featured Products
  • Foodservice
  • MSDS Datasheets
• Programs
  • Promotional Flyer
  • Product News
  • Seasonal Pre-Book
  • First Out Program
  • Trade Show
  • WAM Partnership
• Services
  • Store Merchandising
  • Beverage Services
  • Sales Consultants
  • Planogramming
• Systems
  • Management Information
  • Retailer Operation
  • Website Services
• Contact Us
  • Directions
  • Social Media
• Careers
• Online Ordering
  • ZiiZii Login
  • ZiiZii Registration

FDA Denies Two Vuse Menthol E-Cigarette Products

The Food and Drug Administration issued marketing denial orders to R.J. Reynolds Vapor Co., including the Vuse Vibe Tank Menthol

By Emily Boes || January 24, 2023 || Originally posted on cstoredecisions.com

The U.S. Food and Drug Administration (FDA) issued marketing denial orders (MDOs) to R.J. Reynolds Vapor Co. for two of the company’s menthol e-cigarette products. The currently marketed products include the Vuse Vibe Tank Menthol 3.0% and the Vuse Ciro Cartridge Menthol 1.5%. The company may resubmit applications or submit new applications to address the deficiencies for the products that are subject to these MDOs.

“Consistent with the authorities granted by Congress, the FDA remains committed to evaluating new tobacco product applications based on a public health standard that considers the risks and benefits of the tobacco product to the population as a whole,” said Brian King, Ph.D., M.P.H., director of the FDA’s Center for Tobacco Products. “The applications for these products did not present sufficient scientific evidence to show that the potential benefit to adult smokers outweighs the risks of youth initiation and use.”

After reviewing the company’s premarket tobacco product applications (PMTAs), the FDA determined that the applications lacked sufficient evidence to demonstrate that permitting the marketing of the products would be appropriate for the protection of the public health, which is the applicable standard legally required by the 2009 Family Smoking Prevention and Tobacco Control Act.

These products cannot be legally introduced into interstate commerce in the U.S. without risking FDA enforcement. In addition to ensuring that the manufacturer complies with this order, as with unauthorized products generally, the FDA intends to ensure compliance by distributors and retailers. Retailers should contact R.J. Reynolds Vapor Co. with any questions about products in their inventory.

The agency has completed the review of and made determinations on more than 99% of the nearly 6.7 million deemed products for which applications were submitted by a court-ordered Sept. 9, 2020, deadline. To date, the FDA has authorized 23 tobacco-flavored e-cigarette products and devices. These are the only e-cigarette products that currently may be lawfully sold in the U.S.